This site is intended for healthcare professionals
Whats on the horizon?
  • Home
  • /
  • News
  • /
  • 2016
  • /
  • 04
  • /
  • Launch of LAL-Deficiency Knowledge Centre

Launch of LAL-Deficiency Knowledge Centre

Read time: 1 mins
Last updated:14th Apr 2016
Published:14th Apr 2016
Source: Pharmawand

The Lysosomal Acid Lipase Deficiency (LAL-D) Knowledge Centre has now launched on, intended for healthcare professionals involved in the treatment and management of patients with this condition. 

LAL deficiency is an autosomal recessive lysosomal storage disorder resulting in marked lysosomal accumulation of cholesteryl esters and triglycerides. The two major phenotypes of this condition are an early onset phenotype primarily affecting infants (formerly known as Wolman disease), and a late onset phenotype – also called cholesteryl ester storage disease (CESD). 

Users of this educational resource can expect to find clinical content arranged within three main sections:

Disease Awareness: including epidemiology, pathophysiology, genotypic presentation, diagnosis, prognosis and more…

Treatment: presents the drug characteristics, safety and efficacy of Sebelipase alfa – the first and only licenced treatment for LAL-deficiency

Resources: useful external links, events calendar and a video channel with short expert video discussions on topics such as diagnostic approach and current prognosis.

Developed by EPG Health Media (Europe) Ltd for, in collaboration and with content provided by Alexion Pharma GmbH

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.